Lumiracoxib
Product Specifications
CAS Number
220991-20-8
Target
COX
Related Pathways
Neuroscience|||Immunology/Inflammation
Purity
0.9977
Bioactivity
Lumiracoxib (Prexige) is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 ?M and 0.06 ?M, exhibits 515-fold selectivity over COX-1. Phase 4.
Smiles
N(C1=C(CC(O)=O)C=C(C)C=C1)C2=C(Cl)C=CC=C2F
Molecular Formula
C15H13ClFNO2
Molecular Weight
293.72
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1227871-01 0.02 mg (E-Coli)
Recombinant Leptospira biflexa serovar Patoc Lipoyl synthase (lipA)
Ask
View Details 
MBS1227871-02 0.02 mg (Yeast)
Recombinant Leptospira biflexa serovar Patoc Lipoyl synthase (lipA)
Ask
View Details 
MBS1227871-03 0.1 mg (E-Coli)
Recombinant Leptospira biflexa serovar Patoc Lipoyl synthase (lipA)
Ask
View Details 
MBS1227871-04 0.1 mg (Yeast)
Recombinant Leptospira biflexa serovar Patoc Lipoyl synthase (lipA)
Ask
View Details MBS1227871-05 0.02 mg (Baculovirus)
Recombinant Leptospira biflexa serovar Patoc Lipoyl synthase (lipA)
Ask
View Details MBS1227871-06 0.02 mg (Mammalian-Cell)
Recombinant Leptospira biflexa serovar Patoc Lipoyl synthase (lipA)
Ask
View Details